Furtherly, mice that have been manipulated to carry a mutated p53 gene (that is defective in initiating apoptosis but still able to induce cell cycle arrest (p53R172P, the murine equivalent to human p53R175P) suffer earlier from cancer than p53 wild-type mice but survive longer than p53-null mice [227]. This evidence concerns the gene TP53 and cancer.